- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06652386
Nurse-Led Telemedicine Versus In-Person Lactation Support for Breastfeeding Initiation of Low-Birth-Weight Infants
Nurse-Led Telemedicine Versus In-Person Lactation Support for Breastfeeding Initiation in Mothers of Low-Birth-Weight Infants: A Non-inferiority Randomized Controlled Trial.
Study Overview
Status
Intervention / Treatment
Detailed Description
Breastfeeding offers unparalleled health benefits for infants and mothers, including optimal nutrition, immune protection, and enhanced bonding. These benefits are especially critical for low-birth-weight infants, who are at increased risk for morbidity and mortality. Despite the recognized importance, mothers of low birth weight (LBW) infants often face barriers to initiating and maintaining breastfeeding due to factors such as neonatal intensive care unit (NICU) admissions, maternal stress, and lack of specialized support.
Telemedicine in Lactation Support Telemedicine has emerged as a promising avenue for delivering healthcare services, including lactation support. It offers increased accessibility and convenience, particularly for mothers who may face challenges attending in-person consultations. While telemedicine has been successfully implemented in various healthcare domains, its effectiveness compared to traditional in-person lactation support requires further investigation, particularly among mothers of LBW infants.
Nurses play a pivotal role in providing education, emotional support, and practical assistance to breastfeeding mothers.Understanding how nursing interventions can be optimized in telemedicine versus in-person settings is essential for enhancing breastfeeding initiation.
Objectives
- To compare breastfeeding initiation rates between mothers receiving telemedicine lactation support and those receiving in-person support.
- To assess changes in breastfeeding self-efficacy using the BSES-SF.
- To evaluate maternal satisfaction with the mode of lactation support received.
- To measure maternal anxiety and stress levels using the STAI.
- To monitor infant growth parameters up to 3 months postpartum.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Gharbia Governorate
-
Tanta, Gharbia Governorate, Egypt, 2014
- Tanta University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Mothers aged ≥18 years.
- Mothers of infants with a birth weight <2,500 grams.
- Mothers intend to breastfeed.
- Access to a smartphone, tablet, or computer with internet capability for the telemedicine group.
Exclusion Criteria:
- Infants with congenital anomalies affecting feeding.
- Mothers with medical conditions contraindicating breastfeeding.
- Non-English-speaking mothers (due to resource limitations).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Telemedicine Group
|
|
|
No Intervention: In-Person Group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Breastfeeding effectiveness and initiation success.
Time Frame: after 6 months
|
Breastfeeding effectiveness assessment wil be done by using LATCH Scoring System that incldued 5 items; Each category is scored from 0 to 2, with a maximum possible score of 10.
A higher score indicates better breastfeeding effectiveness, while lower scores suggest areas needing improvement.
The LATCH tool helps healthcare providers to identify and support mothers who may face challenges with breastfeeding.
|
after 6 months
|
|
Maternal satisfaction levels with lactation support received
Time Frame: At 4 weeks postpartum
|
Maternal satisfaction levels with lactation support received will be done using Maternal Breastfeeding Evaluation Scale (MBFES). It measures maternal attitudes, perceptions, and feelings about breastfeeding over time, making it valuable for evaluating the overall breastfeeding experience, especially in terms of emotional and practical aspects. The MBFES is typically divided into three main subscales:1. Infant Satisfaction/Growth, 2. Maternal Enjoyment/Role Attainment, and 3. Lifestyle and Physical Impact. Mothers respond to statements on a Likert scale, typically from "strongly disagree" to "strongly agree." The total score reflects the mother's overall breastfeeding experience, with higher scores indicating a more positive experience. Lower scores may point to areas where mothers might need support or guidance, such as managing discomfort or time constraints. |
At 4 weeks postpartum
|
|
Breastfeeding Self-Efficacy
Time Frame: at baseline (after delivery) and at 4 week postpartum
|
The Breastfeeding Attrition Prediction Tool (BAPT) is a psychometric instrument developed to predict a mother's likelihood of discontinuing breastfeeding. The BAPT assesses various factors influencing breastfeeding behavior and attitudes, which can predict the attrition risk.The tool is composed of four main subscales:1. Positive Breastfeeding Sentiment,2. Negative Breastfeeding Sentiment, 3. Social and Professional Support , and 4. Perceived Barriers: Responses are typically recorded on a Likert scale ranging from "strongly disagree" to "strongly agree." A higher score on the "Positive Breastfeeding Sentiment" subscale indicates a stronger commitment to breastfeeding, while higher scores on the other subscales (negative sentiment, barriers) may predict higher attrition risk. The overall score gives healthcare providers insight into wheth |
at baseline (after delivery) and at 4 week postpartum
|
|
Exclusive Breastfeeding Duration
Time Frame: up to 6 months postpartum
|
Duration and exclusivity of breastfeeding will be followed up by Weekly phone calls to mothers up to 6 months postpartum to collect breastfeeding data.
|
up to 6 months postpartum
|
|
Infant Growth Parameter - Weight
Time Frame: Up to 3 months postpartum
|
"Infant weight will be measured in kilograms (Kg) using a baby scale at birth, 4 weeks, and 3 months postpartum.
Trained nurses will perform the measurements using standardized equipment and techniques, following World Health Organization (WHO) guidelines."
|
Up to 3 months postpartum
|
|
Infant Growth Parameter- Length
Time Frame: Up to 3 months postpartum
|
Length will be measured in centimeters (cm) using a measurement tape.
These anthropometric measurements will be taken by trained nurses at birth, 4 weeks, and 3 months postpartum.
Standardized equipment and techniques, adhering to World Health Organization (WHO) guidelines, will be employed."
|
Up to 3 months postpartum
|
|
Infant Growth Parameter- Head circumference
Time Frame: Up to 3 months postpartum
|
Head circumference will be measured in centimeters (cm) using a measurement tape.
These anthropometric measurements will be taken by trained nurses at birth, 4 weeks, and 3 months postpartum.
Standardized equipment and techniques, adhering to World Health Organization (WHO) guidelines, will be employed."
|
Up to 3 months postpartum
|
|
Maternal Anxiety and Stress
Time Frame: at baseline (after delivery) and at 4 week postpartum
|
State-Trait Anxiety Inventory (STAI) will be used to assss the level of maternal anxiety and stress.
The STAI consists of 40 self-report questions, with 20 items each for state anxiety and trait anxiety.
Respondents rate how they feel "right now" (state anxiety) or how they "generally" feel (trait anxiety), typically on a 4-point Likert scale.
|
at baseline (after delivery) and at 4 week postpartum
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 530-9-2024
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Telemedicine
-
Michigan State UniversityUniversity of Michigan; Wake Forest University Health Sciences; Babes-Bolyai...CompletedUsual Care | Telemedicine: Smoking Cessation App Only | Telemedicine: Smoking Cessation Counseling | Telemedicine: App + CounselingRomania
-
Attune Health Research, Inc.Rheumatology Research FoundationRecruiting
-
University Hospital, Basel, SwitzerlandInnosuisse - Swiss Innovation AgencyCompleted
-
Wake Forest University Health SciencesCompleted
-
National University Health System, SingaporeCompletedTelemedicineSingapore
-
CochlearCompletedTelemedicineUnited States
-
The Hong Kong Polytechnic UniversityCompleted
-
Wake Forest University Health SciencesCompleted
-
Buzzi Children's HospitalCompleted
Clinical Trials on Telemedicine Group
-
University of MichiganCompleted
-
University of Alabama at BirminghamChildren's of AlabamaCompleted
-
University Hospital, Strasbourg, FranceUnknown
-
Eskisehir Osmangazi UniversityEskisehir City HospitalEnrolling by invitationStress Urinary IncontinenceTurkey
-
University of California, Los AngelesRally Foundation for Childhood Cancer Research; Bear Necessities Pediatric...Completed
-
Peking Union Medical College HospitalCompletedBlood Glucose | Compliance, Patient | Diet Habit | Pregnancy Outcome | Maternal Behavior | Mobile Health | GDMChina
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); University of Pennsylvania; Washington University... and other collaboratorsCompleted
-
Sociedad Andaluza de Endocrinología, Diabetes y...Completed
-
Chang Hee, LeePurdue University; LG Electronics Inc.CompletedHypertensionKorea, Republic of